Successful Treatment of Ultrasound-confirmed Synovitis in Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis with Corticosteroid Therapy

Intern Med. 2024;63(10):1473-1478. doi: 10.2169/internalmedicine.2382-23. Epub 2024 May 15.

Abstract

Anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive clinically amyopathic dermatomyositis (CADM) is a subtype of dermatomyositis without severe myositis but with characteristic cutaneous manifestations and severe interstitial lung disease. Joint symptoms can occur in patients with anti-MDA5 antibody-positive CADM. However, the treatment strategy and utility of ultrasound for treating joint symptoms remain unknown. We herein report an 85-year-old man with anti-MDA5 antibody-positive CADM who presented with ultrasound-confirmed synovitis that improved with medium-dose corticosteroid therapy.

Keywords: CADM; anti-MDA5 antibody; synovitis; ultrasound.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Aged, 80 and over
  • Autoantibodies* / blood
  • Autoantibodies* / immunology
  • Dermatomyositis* / complications
  • Dermatomyositis* / diagnostic imaging
  • Dermatomyositis* / drug therapy
  • Dermatomyositis* / immunology
  • Humans
  • Interferon-Induced Helicase, IFIH1* / immunology
  • Male
  • Synovitis* / diagnostic imaging
  • Synovitis* / drug therapy
  • Synovitis* / etiology
  • Synovitis* / immunology
  • Treatment Outcome
  • Ultrasonography*